ITGAV and hereditary elliptocytosis: When shRNAs were applied to the cells at the stage of HE development (Days 2‐4), the frequency and the number of CD43+ HPCs were significantly decreased by knockdown of either ITGB3, ITGB5 or ITGAV (Figure 6B,C).